Minerva Neurosciences, Inc. (NERV) Form 10-Q Quarterly Reports
Minerva Neurosciences, Inc. (NERV) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NERV
CIK: 1598646
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: MA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerReid Mountjoy
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-08-20 | 2026-08-10 | 3 Filing | 0001610499-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-08-20 | 2026-08-10 | 3 Filing | 0002149586-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003429 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000908834-26-000403 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-10 | 8-K | 0001193125-26-346817 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001193125-26-339171 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001193125-26-339147 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-08-03 | 4 Filing | 0002095703-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001623632-26-000988 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0001405279-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0001610384-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0001642015-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0001642053-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0002095703-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0001021040-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0001226286-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-04 | 2026-06-03 | 8-K | 0001193125-26-257379 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | 8-K | 0001193125-26-241930 | View SEC Doc Filr Page |
| 424B5 | 2026-05-27 | — | 424B5 | 0001193125-26-241915 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-15 | — | SCHEDULE 13G Filing | 0001274173-26-000130 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001193125-26-225087 | View SEC Doc Filr Page |
| 10-Q | 2026-05-05 | 2026-03-31 | 10-Q | 0001193125-26-205182 | View SEC Doc Filr Page |
| 8-K | 2026-05-05 | 2026-05-05 | 8-K | 0001193125-26-205129 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001193125-26-171814 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001193125-26-171805 | View SEC Doc Filr Page |